Skip to main content
SpringerLink
Log in
Book cover

Translational Oral Health Research pp 7–18Cite as

How Cross-Disciplinary Research Has Increased Our Understanding of Oral Mucosal Diseases

  • Chapter
  • First Online:

Abstract

Over the last 40 years, research in dental schools has moved from a position where clinicians were expected to make a scientific contribution to their fields on their own, to a fruitful multidisciplinary approach to answering basic questions about the disease process. At one time, clinicians hoping to make an academic contribution were expected to learn basic laboratory techniques in order to do so. Indeed, the foundation of current multidisciplinary research was that this approach was relatively successful. However, it became apparent that successful high-impact contributions required expertise that cannot any longer reside in individuals but in groups. Both the scientific questions and the means of addressing them have become increasingly complex and require a wide range of expertise. This applies not only to laboratory-based research but to clinically applied research. The former needs interactions with expert nonclinical scientists and the latter interactions with expert clinicians from different fields in order to maximise the investigation and management of complex clinical diseases. In oral medicine, there are now many examples of both types of multidisciplinary approach, which have resulted in a marked increase in our knowledge of disease mechanisms in mucosal disease which have in turn led to new approaches to treatment.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Tappuni AR, Kovacevic T, Shirlaw PJ, Challacombe SJ. Clinical assessment of disease severity in recurrent aphthous stomatitis. J Oral Pathol Med. 2013;42(8):635–41.

    Article  Google Scholar 

  2. Escudier M, Ahmed N, Shirlaw P, et al. A scoring system for mucosal disease severity with special reference to oral lichen planus. Br J Dermatol. 2007;157(4):765–70.

    Article  Google Scholar 

  3. Ormond M, McParland H, Donaldson ANA, Andiappan M, Cook RJ, Escudier M, Hullah E, Higham J, McMillan R, Taylor J, Shirlaw PJ, Challacombe SJ, Setterfield JF. An Oral Disease Severity Score (ODSS) validated for use in oral pemphigus vulgaris. Br J Dermatol. 2018. https://doi.org/10.1111/bjd.16265.

  4. Setterfield J, Shirlaw PJ, Bhogal BS, Tilling K, Challacombe SJ, Black MM. Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity. Br J Dermatol. 1999;140(4):645–50.

    Article  Google Scholar 

  5. Campbell H, Escudier MP, Brostoff J, Patel P, Milligan P, Challacombe SJ, Sanderson JD, Lomer MC. Dietary intervention for oral allergy syndrome as a treatment in orofacial granulomatosis: a new approach? J Oral Pathol Med. 2013;42(7):517–22.

    Article  Google Scholar 

  6. Osailan S, Pramanik R, Shirodaria S, Challacombe SJ, Proctor GB. Investigating the relationship between hyposalivation and mucosal wetness. Oral Dis. 2011;17(1):109–14.

    Article  Google Scholar 

  7. Setterfield J, Shirlaw PH, Kerr-Muir M, Bhogal BS, Morgan PR, Challacombe SJ, Tilling K, Black MM. Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol. 1998;138:602–10.

    Article  Google Scholar 

  8. Ali S, Kelly C, Challacombe SJ, Donaldson AN, Bhogal BS, Setterfield JF. Serum and salivary IgG and IgA antibodies to Dsg3 in mucosal pemphigus vulgaris. Br J Dermatol. 2016a;175:113–21.

    Article  Google Scholar 

  9. Ali S, Kelly C, Challacombe SJ, Donaldson AN, Dart JK, Gleeson M, MMP Study Group 2009–2014, Setterfield JF. Salivary IgA and IgG antibodies to BP180-NC16a as diagnostic biomarkers in Mucous Membrane Pemphigoid. Br J Dermatol. 2016b;174(5):1022–9.

    Article  Google Scholar 

  10. Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol. 2001;144:775–80.

    Article  Google Scholar 

  11. Oyama N, Setterfield JF, Powell AM, Sakuma-Oyama Y, Albert S, Bhogal BS, Vaughan RW, Kaneko F, Challacombe SJ, Black MM. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Br J Dermatol. 2006;154(1):90–8.

    Article  Google Scholar 

  12. Harman KE, Gratian MJ, Shirlaw PJ, Bhogal BS, Challacombe SJ, Black MM. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. Br J Dermatol. 2002;146:684–7.

    Article  Google Scholar 

  13. Harman KE, Gratian MJ, Seed PT, Bhogal BS, Challacombe SJ, Black MM. An evaluation of ELISA for detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3: a sensitive tool to aid the diagnosis and differentiation of pemphigus vulgaris and foliaceus. Clin Exp Dermatol. 2000;25:236–40.

    Article  Google Scholar 

  14. White A, Nunes C, Escudier M, Lomer MC, Barnard K, Shirlaw P, Challacombe SJ, Sanderson JD. Improvement in orofacial granulomatosis on a cinnamon- and benzoate-free diet. Inflamm Bowel Dis. 2006;12(6):508–14.

    Article  Google Scholar 

  15. Campbell HE, Escudier MP, Patel P, Challacombe SJ, Sanderson JD, Lomer MC. Cinnamon- and benzoate-free diet as a primary treatment for orofacial granulomatosis. Aliment Pharmacol Ther. 2011a;34(7):687–701.

    Article  Google Scholar 

  16. Campbell H, Escudier M, Patel P, Nunes C, Elliott TR, Barnard K, Shirlaw P, Poate T, Cook R, Milligan P, Brostoff J, Mentzer A, Lomer MC, Challacombe SJ, Sanderson JD. Distinguishing orofacial granulomatosis from Crohn’s disease: two separate disease entities? Inflamm Bowel Dis. 2011b;17:2109–15.

    Article  Google Scholar 

  17. Elliott E, Campbell H, Escudier M, Poate T, Nunes C, Lomer M, Mentzer A, Patel P, Shirlaw P, Brostoff J, Challacombe S, Sanderson J. Experience with anti-TNF-α therapy for orofacial granulomatosis. J Oral Pathol Med. 2011;40(1):14–9.

    Article  Google Scholar 

  18. Mentzer A, Nayee S, Omar Y, Hullah E, Taylor K, Goel R, Bye H, Shembesh T, Elliott TR, Campbell H, Patel P, Nolan A, Mansfield J, Challacombe SJ, Escudier M, Mathew CG, Sanderson JD, Prescott NJ. Genetic association analysis reveals differences in the contribution of NOD2 variants to the clinical phenotypes of orofacial granulomatosis. Inflamm Bowel Dis. 2016b;22(7):1552–8.

    Article  Google Scholar 

  19. Patel P, Barone F, Nunes C, Boursier L, Odell E, Escudier M, Challacombe S, Brostoff J, Spencer J, Sanderson J. Subepithelial dendritic B cells in orofacial granulomatosis. Inflamm Bowel Dis. 2010;16(6):1051–60.

    Article  Google Scholar 

  20. Patel P, Brostoff J, Campbell H, Goel RM, Taylor K, Ray S, Lomer M, Escudier M, Challacombe S, Spencer J, Sanderson J. Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease. Clin Transl Allergy. 2013;3(1):26.

    Article  Google Scholar 

  21. Mentzer A, Goel R, Elliott T, Campbell H, Hullah E, Patel P, Challacombe S, Escudier M, Sanderson JD. Azathioprine is effective for oral involvement in Crohn’s disease but not for orofacial granulomatosis alone. J Oral Pathol Med. 2016a;45(4):312–8.

    Article  Google Scholar 

  22. Sanderson J, Nunes C, Escudier M, Barnard K, Shirlaw P, Odell E, Chinyama C, Challacombe S. Oro-facial granulomatosis: Crohn’s disease or a new inflammatory bowel disease? Inflamm Bowel Dis. 2005;11(9):840–6.

    Article  Google Scholar 

  23. Kassimos DG, Shirlaw PJ, Choy EHS, Hockey K, Morgan PR, Challacombe SJ, Panayi GS. Chronic sialadenitis in patients with nodal osteoarthritis. Br J Rheumatol. 1997;36:1312–7.

    Article  Google Scholar 

  24. Pramanik R, Osailan SM, Challacombe SJ, Urquhart D, Proctor GB. Protein and mucin retention on oral mucosal surfaces in dry mouth patients. Eur J Oral Sci. 2010;118(3):245–53.

    Article  Google Scholar 

  25. Proctor GB, Osailan S, Pramanik R, Shirlaw PJ, Challacombe SJ. Drug related hyposalivation: a review of physiology and sites of drug action. Oral Dis. 2010;16(6):505–15.

    Article  Google Scholar 

  26. Daniels TE, Criswell LA, Shiboski C, Shiboski S, Lanfranchi H, Dong Y, Schiødt M, Umehara H, Sugai S, Challacombe S, Greenspan JS, Sjögren’s International Collaborative Clinical Alliance Research Groups. An early view of the international Sjögren’s syndrome registry. Arthritis Rheum. 2009;61(5):711–4.

    Article  Google Scholar 

  27. Shiboski CH, Baer AN, Shiboski SC, Lam M, Challacombe S, Lanfranchi HE, Schiødt M, Shirlaw P, Srinivasan M, Umehara H, Vivino FB, Akpek E, Bunya V, Vollenweider CF, Greenspan JS, Daniels TE, Criswell LA, Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups. Natural history and predictors of progression to Sjögren’s syndrome among participants of the SICCA registry. Arthritis Care Res (Hoboken). 2017b;24. https://doi.org/10.1002/acr.23264.

  28. Shiboski SC, Shiboski CH, Criswell LA, Baer A, Challacombe S, Lanfranchi H, et al.; for the Sjögren’s International Collaborative Clinical Alliance Research Groups. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64(4):475–487.

    Article  Google Scholar 

  29. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjögren’s Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017a;76(1):9–16.

    Article  Google Scholar 

  30. Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara NA, Greenspan JS, Daniels TE, Sjögren’s International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol. 2010;149(3):405–15.

    Article  Google Scholar 

  31. Taylor KE, Wong Q, Levine DM, McHugh C, Laurie C, Doheny K, Lam MY, Baer AN, Challacombe S, Lanfranchi H, Schiødt M, Srinivasan M, Umehara H, Vivino FB, Zhao Y, Shiboski SC, Daniels TE, Greenspan JS, Shiboski CH, Criswell LA. Genome-wide association analysis reveals genetic heterogeneity of Sjögren’s syndrome according to ancestry. Arthritis Rheumatol. 2017;69(6):1294–305.

    Article  Google Scholar 

  32. Osailan SM, Pramanik R, Shirlaw P, Proctor GB, Challacombe SJ. Clinical assessment of oral dryness: development of a scoring system related to salivary flow and mucosal wetness. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(5):597–603.

    Article  Google Scholar 

  33. Daniels TE, Cox D, Shiboski CH, Schiødt M, Wu A, Lanfranchi H, et al.; and Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren’s syndrome (SS) among 1726 registry participants. Arthritis Rheum. 2011;63(7):2021–2030.

    Google Scholar 

  34. Baer AN, McAdams DeMarco M, Shiboski SC, Lam MY, Challacombe S, Daniels TE, Dong Y, Greenspan JS, Kirkham BW, Lanfranchi HE, Schiødt M, Srinivasan M, Umehara H, Vivino FB, Vollenweider CF, Zhao Y, Criswell LA, Shiboski CH, Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren’s syndrome. Ann Rheum Dis. 2015;74(8):1557–61.

    Article  Google Scholar 

  35. Barone F, Bombardieri M, Rosado MM, Morgan PR, Challacombe SJ, De Vita S, Carsetti R, Spencer J, Valesini G, Pitzalis C. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren’s syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol. 2008;180(7):5130–40.

    Article  Google Scholar 

  36. Challacombe SJ, Shirlaw PJ, Thornhill MH. Chapter 102: Immunology of diseases of the oral cavity. In: Mestecky J, Strober W, Russell MW, Kelsall BL, Cheroutre H, Lambrecht BN, editors. Mucosal immunology. 4th ed. UK: Elsevier Ltd; 2016. p. 1943–83.

    Google Scholar 

Download references

Acknowledgements

To all those colleagues who share enthusiasm for multidisciplinary clinics including Oral Medicine, Jane Setterfield, Pepe Shirlaw, Michael Escudier, Anwar Tappuni, Richard Cook and Helen McParland; Gastroenterology, Jeremy Sanderson, Pritash Patel and Carlo Nunes; Dieticians, Miranda Lomer and Helen Campbell; Oral Pathology, Peter Morgan and Eddie Odell; Rheumatology, Bruce Kirkham, Francesca Barone and Gabriel Panayi; Dermatology, Martin Black, Jane Setterfield and Anne Marie Powell; Immunofluorescent laboratory, Balbir Bhogal and Matthew Gratian; Immunology, Charles Kelly and Jo Spencer; Salivary Research Unit, Gordon Proctor, Samira Osailan, Rashida Pramanik and Guy Carpenter; and Ophthalmology, Genevieve Larkin and John Dart.

Author information

Authors and Affiliations

  1. Department of Oral Medicine, King’s College London Dental Institute, Guy’s and St Thomas’ NHS Foundation Trust at Guy’s Hospital, London, SE1 9RT, UK

    S. J. Challacombe, H. McParland, J. F. Setterfield, M. Escudier & P. J. Shirlaw

  2. Department of Mucosal and Salivary Biology, King’s College London Dental Institute at Guy’s Hospital, London, SE1 9RT, UK

    G. Proctor

  3. Department of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust at Guy’s Hospital, London, SE1 9RT, UK

    J. F. Setterfield

  4. Department of Gastroenterology, Guy’s and St Thomas’ NHS Foundation Trust at Guy’s Hospital, London, SE1 9RT, UK

    J. Sanderson

  5. Department of Rheumatology, Guy’s and St Thomas’ NHS Foundation Trust at Guy’s Hospital, London, SE1 9RT, UK

    B. Kirkham

  6. Department of Ophthalmology, Kings College Hospital, London, SE1 9RT, UK

    G. Larkin

Authors
  1. S. J. Challacombe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. McParland
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Proctor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. F. Setterfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Escudier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Sanderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Kirkham
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Larkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. J. Shirlaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. J. Challacombe .

Editor information

Editors and Affiliations

  1. Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland

    Jukka H. Meurman

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Challacombe, S.J. et al. (2018). How Cross-Disciplinary Research Has Increased Our Understanding of Oral Mucosal Diseases. In: Meurman, J. (eds) Translational Oral Health Research. Springer, Cham. https://doi.org/10.1007/978-3-319-78205-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78205-8_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78204-1

  • Online ISBN: 978-3-319-78205-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation